Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene

被引:31
作者
Chertin, B [1 ]
De Caluwé, D
Puri, P
机构
[1] Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland
[2] Natl Childrens Hosp, Dublin, Ireland
[3] Childrens Hosp Temple St, Dublin, Ireland
[4] Univ Coll Dublin, Dublin 2, Ireland
关键词
vesico-ureteral reflux; ureter; polytetrafluoroethylene; endoscopy;
D O I
10.1097/01.ju.0000062300.71507.3a
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluated our experience with endoscopic STING (subureteral polytetrafluoroethylene injection) for grades IV and V vesicoureteral reflux. Materials and Methods: We reviewed the records of 221 boys and 305 girls who underwent STING for primary grades IV (430) and V (96) vesicoureteral reflux between 1984 and 2000. Median patient age at STING was 3 years (range 3 months to 14 years). Reflux was unilateral and bilateral in 335 and 191 children, respectively (717 refluxing units). Median followup was 11.6 years (range 1 to 17). Results: Reflux was corrected in 420 of the 717 refluxing units (58%) after a single injection. Reflux resolved after a second and third injection in 185 ureters (26%). High grade reflux was converted to grades I and II in 112 ureters (15%) and did not require any further treatment. STING failed to correct reflux in 7 units (0.9%), which were managed by ureteral reimplantation (5) and nephrectomy (2) due to poor renal function. Voiding cystourethrography showed recurrent vesicoureteral reflux in 9 units (1.2%), including 2 with low grade reflux for which no treatment was given. Seven ureters required repeat injection due to grades III and IV reflux. No untoward effects were noted in any patients in whom polytetrafluoroethylene was used as the injected material. Conclusions: STING is a simple, safe and effective outpatient procedure for grades IV and V vesicoureteral reflux.
引用
收藏
页码:1847 / 1849
页数:3
相关论文
共 20 条
[1]  
[Anonymous], 1987, Br Med J (Clin Res Ed), V295, P237
[2]   Endoscopic treatment of vesico-ureteral reflux: Twelve years' experience [J].
Capozza, N ;
Patricolo, M ;
Lais, A ;
Matarazzo, E ;
Caione, P .
UROLOGIA INTERNATIONALIS, 2001, 67 (03) :228-231
[3]  
Chaffange P, 2001, PROG UROL, V11, P546
[4]   Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup [J].
Chertin, B ;
Colhoun, E ;
Velayudham, M ;
Puri, P .
JOURNAL OF UROLOGY, 2002, 167 (03) :1443-1445
[5]  
Elder J S, 2000, Curr Opin Urol, V10, P579, DOI 10.1097/00042307-200011000-00008
[6]   Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children [J].
Elder, JS ;
Peters, CA ;
Arant, BS ;
Ewalt, DH ;
Hawtrey, CE ;
Hurwitz, RS ;
Parrott, TS ;
Snyder, HM ;
Weiss, RA ;
Woolf, SH ;
Hasselblad, V .
JOURNAL OF UROLOGY, 1997, 157 (05) :1846-1851
[7]  
ELDER JS, 1997, REPORT MANAGEMENT PR
[8]   Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up [J].
Haferkamp, A ;
Contractor, H ;
Möhring, K ;
Staehler, G ;
Dörsam, J .
UROLOGY, 2000, 55 (05) :759-763
[9]   Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: A North American clinical report [J].
Herz, D ;
Hafez, A ;
Bagli, D ;
Capolicchio, G ;
McLorie, G ;
Khoury, A .
JOURNAL OF UROLOGY, 2001, 166 (05) :1880-1886
[10]   New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux [J].
Kershen, RT ;
Atala, A .
UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (01) :81-+